In SURPASS-2, a head-to-head in T2D patients, tirzepatide 15 mg produced 11.2 kg weight loss versus 5.7 kg on semaglutide 1 mg (the T2D dose at the time, not the 2.4 mg obesity dose)
Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: A multidisciplinary expert consensus
If youre on semaglutide or tirzepatide and youre not training with resistance and eating adequate protein, youre wasting the opportunity
You have GLP-1 receptors in your: Digestive system: It slows down how quickly food leaves your stomach, which helps you feel full longer
The pyridoxine advantage becomes most apparent during the first dose increase, from 0.25 mg to 0.5 mg
If you or a loved one is considering Semaglutide for weight loss, consult a healthcare professional to explore the potential benefits and determine the most suitable course of action for your unique health profile